UCSF Benioff Children's Hospital

Oakland, California 94618

10 studies enrolling now · 30 studies all time

What they study most

Achondroplasia, Acute Lymphoblastic Leukemia, Pediatric, Adolescent Behavior, Anemia, Hemolytic, Blood and Lymphatic Diseases, Cervical Spine Injury, Child Behavior, Chronic Anemia, Contrast Media Adverse Reaction, GM1 Gangliosidosis, Genetic Disease, Genetic Diseases, X-Linked

Studies at this site

• Evaluation of Analgesia for Cardiac Elective Surgery in Children — Recruiting now
• Prospective Clinical Assessment Study in Children With Hypochondroplasia — Recruiting now
• Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. — Recruiting now
• Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH) — Recruiting now
• Rett Syndrome Registry — Recruiting now
• Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA) — Recruiting now
• A Multicenter Multinational Observational Study of Children With Hypochondroplasia — Recruiting now
• An Interventional Study of Infigratinib in Children With Hypochondroplasia — Enrolling by invitation
• Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia — Enrolling by invitation
• Development and Testing of a Pediatric Cervical Spine Injury Risk Assessment Tool — Completed
• Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment — Running, not enrolling
• Starzl Network Patient Reported Outcomes — Completed
• Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400. — Running, not enrolling
• Study of Infigratinib in Children With Achondroplasia — Completed
• GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO) — Completed
• A Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell Disease — Completed
• A Study of Tividenofusp Alfa (DNL310) in Pediatric Participants With Hunter Syndrome — Running, not enrolling
• Biology and Benefits of Music Play and Stories for Kids/Parents During ALL Treatment — Completed
• A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301 — Enrolling by invitation
• Assessment of CSF Shunt Flow With Thermal Measurements B — Completed
• A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY) — Running, not enrolling
• Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients — Completed
• Use of a Water Soluble Contrast-Based Protocol to Assist in the Management of Pediatric Adhesive Small Bowel Obstruction — Completed
• A Study of Potential Treatment-Responsive Biomarkers and Clinical Outcomes in Hunter Syndrome — Completed
• Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients — Completed
• A Study Evaluating the Efficacy and Safety of AG-348 in Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD) — Completed
• Safety Study for Beta Thalassemia Subjects on PTG-300 — Completed
• Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia — Completed
• Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies — Stopped early
• Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC) — Completed